How to Formulate a Cosmetic Product for 2027

Most formulation guides teach you to start with a benefit and pick ingredients that deliver it. That still works — but in 2026 it is no longer enough, because a formula that performs beautifully can become unsellable on a fixed date. This guide adds the two things missing from the standard method: the 2027 regulatory constraints, and the current generation of actives that most local supply chains have not caught up with.

What actually changes in 2027?

Three EU changes arrive inside six months, and one US proposal is close behind:

The D5 restriction is the one that will catch most people. Cyclopentasiloxane is in an enormous number of leave-on products — primers, serums, sunscreens, hair care — routinely at 3–10%. A 0.1% ceiling is not a tweak; it means rebuilding the sensory system of the product.

Every restriction on this list has a date attached. A formula approved today with 4% D5 in a leave-on product has a known expiry — and reformulating after packaging is printed costs far more than designing around it now.

Step 1 — Build the restriction list before the ingredient list

Reverse the usual order. Before choosing a single active, write down what your target markets will not allow by the time you launch:

• The 2027 EU changes above, if you sell or intend to sell into Europe.
• Local prohibitions, which differ sharply. Egypt's cosmetic claims guidance, for example, prohibits a range of common marketing terms outright — including anti-acne, anti-cellulite, skin tightening and stretch-mark claims — regardless of what the formula can do.
• Category-specific rules — massage products, scar products and hair care each carry their own conditions in some markets.

This list is your design constraint. Everything after it is chosen to fit.

Step 2 — Choose actives from the biotech generation

The centre of gravity in cosmetic actives has shifted from botanical extraction to biotechnology. If your formulator is working from a local supplier catalogue, you are likely to be offered materials that were current five years ago. Current direction:

• Fermented actives and bio-designed peptides — engineered rather than harvested, with more consistent activity batch to batch.
• Lab-grown alternatives to botanicals — microalgae cultivation and advanced fermentation produce nature-identical compounds without harvesting pressure.
• Plant-derived exosomes (flower, avocado) — an emerging delivery-and-signalling category positioned as a more ethical route than animal-derived equivalents.
• MAAs (mycosporine-like amino acids) from marine microorganisms — naturally UV-protective and antioxidant, and of real interest for sun care.
• Upcycled materials — side-streams from food and agriculture, increasingly with genuine performance data rather than only a sustainability story.

Two cautions. Ask whether each material is actually obtainable in your volumes — novelty is worthless if it is single-source or minimum-order-prohibitive. And check whether it is a proprietary active exclusive to one manufacturer, in which case a contract manufacturer may not be able to buy it at all.

Step 3 — Spend on delivery, not only on novelty

This is the least fashionable and most useful advice in this guide. As one industry summary puts it, innovation is not always about new ingredients but about making existing ones perform better.

A well-encapsulated 5% vitamin C that stays stable for two years will outperform a fashionable new active dosed at a level that does nothing. Where to look:

• Stabilised vitamin C systems that survive the shelf rather than browning in three months.
• Encapsulated retinoids that reduce irritation while maintaining activity.
• UV filter delivery — photostabilisers and solubilisation systems that keep filters working, which matters more than the filter list itself.

Step 4 — Design the claim and the formula together

Write the claim you intend to make while the formula is being built, not after. Two checks:

1. Can the formula substantiate it? An active below its effective range cannot support a performance claim, no matter how prominent it is on the label.
2. Is the claim permitted in the market? Some claims are prohibited outright regardless of evidence. Discovering that at registration costs you printed packaging and a launch window.

This is the gap where most products fail — we cover why in why cosmetic brands fail.

Step 5 — Set the cost ceiling before formulating

Work backwards: target retail price → required gross margin → maximum cost per unit → maximum formula cost. Give that number to whoever formulates, at the start. A formula costed after the third trial batch is a formula that gets cut after the story has already been promised.

Step 6 — Verify before you commit to a batch

Before a single kilo is made, the formula should pass a mechanical check — not an opinion:

• Percentages balance to 100. Obvious, and still a common error.
• pH sits within range for every active present, not just the hero.
• The emulsifier load matches the oil phase — under-emulsified systems separate at 40°C, not on your bench.
• Preservation matches water activity, and the system is permitted in every target market.
• Every ingredient is sourceable by your actual manufacturer.
• Nothing on the 2027 list appears above its future limit.

Then validate at the bench. No screening step replaces stability, compatibility and challenge testing — it simply means fewer failed batches reach that stage.

What to remove, and what to reach for instead

Frequently asked questions